Dyne Therapeutics
69 hedge funds and large institutions have $614M invested in Dyne Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.
146% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 13
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
38% more funds holding
Funds holding: 50 → 69 (+19)
12% more capital invested
Capital invested by funds: $550M → $614M (+$64.9M)
3.95% more ownership
Funds ownership: 60.52% → 64.47% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| 1 |
BlackRock
New York
|
+$14.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.16M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.67M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$4.43M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
76
Pinz Capital Management
New York
| – | -$820K | -40,600 | Closed |
|
|
MFS
77
Mirabella Financial Services
London,
United Kingdom
| – | -$556K | -27,558 | Closed |
|
|
FLAM
78
First Light Asset Management
Edina,
Minnesota
| – | -$505K | -25,000 | Closed |
|
79
Squarepoint
New York
| – | -$468K | -23,174 | Closed |
|
80
Point72 Asset Management
Stamford,
Connecticut
| – | -$404K | -20,000 | Closed |
|
|
MS
81
Maven Securities
St Helier,
Jersey
| – | -$212K | -10,600 | Closed |
|
|
ZP
82
Zimmer Partners
New York
| – | -$202K | -10,000 | Closed |
|
DYN Hedge Fund Activity: Q4 2020 in Review
69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2020, worth a combined $614M — up 12% from $550M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new DYN positions and 13 closed out — a net gain of 19 holders — while 13 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $9.58M sold.
- 69 institutional investors held Dyne Therapeutics (DYN) as of Q4 2020, up from 50 in Q3 2020.
- Funds reported $614M of Dyne Therapeutics stock for Q4 2020, up 12% quarter-over-quarter.
- 32 funds opened new Dyne Therapeutics positions in Q4 2020 and 13 closed out, a net change of +19 holders.
- The largest Dyne Therapeutics buyer in Q4 2020 was BlackRock, an estimated $14.5M added.
- The largest Dyne Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $9.58M sold.
Based on aggregated 13F filings for Q4 2020.